
Co-Diagnostics, Inc. Announces Q1 2020 Results and Provides Mid-Second Quarter Update
Company reports robust sales of COVID-19 tests as Co-Diagnostics generates net profit through middle of second quarter Salt Lake City, Utah – May 14, 2020 – Co-Diagnostics, Inc. (Nasdaq:CODX) (the Company), a molecular diagnostics company with a unique, […]